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Background
Recently, a genome-wide association study identified 3
amino acids (residues 67, 70, 97) in the HLA-B peptide
binding groove that explain the classical HLA class I asso-
ciations with HIV-1 immune control. However, how
amino acid substitutions at these positions affect HIV-1
immune defense remains unclear. Leukocyte Immunoglo-
bulin Like Receptors (LILR) are a class of immunoregula-
tory molecules that are expressed on myeloid dendritic
cells and interact with HLA class I molecules as their phy-
siologic ligands. Here, we assessed how different amino
acids in the HLA-B binding groove may influence their
binding to LILRs.
Methods
Using a cell-free assay, the binding strength between 50
HLA-B alleles and recombinant LILRB2-Fc fusion protein
was experimentally determined. Average bindings scores
to LILRB2 were calculated for HLA-B allotypes sharing
identical amino acid residues at position 67, 70 and 97.
For comparison purposes, binding scores to LILRB1 were
similarly determined. The average binding scores were
then correlated to odds ratios reflecting the impact of the
respective amino acids residues at position 67, 70 and 97
on HIV-1 disease progression.
Results
Six amino acid variants at position 97, four amino acid
variants at position 70, and five amino acid variants at
position 67 were included into the analysis. Overall, we
observed an almost perfect inverse correlation between
the odds ratios of each amino acid variant at position 97
on HIV-1 control and LILRB2 binding scores of class I
alleles carrying the respective amino acid variant (R=0.88,
p=0.02). Similar findings were made for amino acid var-
iants at position 70 (R=0.993, p=0.007) and position 67
(R=0.95, p=0.005). No significant correlations were
observed when HLA-LILRB1 binding scores were used
instead of LILRB2.
Conclusion
These data suggest that amino acid polymorphisms at
position 67, 70 and 97 of the HLA-B binding groove
influence HIV-1 immune control through altered inter-
actions with the immunomodulatory LILRB2 receptor.
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